Christopher Burch

Christopher Burch is co-founder and CEO of Cogentis Therapeutics, an early-stage biotechnology startup focused on developing therapeutic treatments for neurodegenerative diseases, including frontotemporal dementia and Alzheimer's disease. He also works as an operational management consultant with a variety of clients, primarily focused on medical process improvement. Chris recently graduated from the Johns Hopkins Carey Business School Global MBA program (class of 2015), with a concentration in Enterprise Risk Management and a focus in behavioral marketing. Prior to business school, he served in the US Army Special Forces as a tactical adviser and instructor.